Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates reveals the emergence of blaOXA-23 and blaNDM-1 encoding international …

S Kumar, PP Patil, L Singhal, P Ray, PB Patil… - Infection, Genetics and …, 2019 - Elsevier
Acinetobacter baumannii is a nosocomial pathogen increasingly affecting the critically ill
patients and represents a major public health challenge. Carbapenem-resistant A …

[HTML][HTML] Dissemination of blaOXA-23-harbouring carbapenem-resistant Acinetobacter baumannii clones in Pakistan

M Khurshid, MH Rasool, UA Ashfaq, B Aslam… - Journal of global …, 2020 - Elsevier
Objectives The rise of carbapenem resistance in Acinetobacter baumannii represents a
challenge for the therapeutic management of infections. The present study aimed to …

Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients

RM Hassan, ST Salem, SIM Hassan, AS Hegab… - PLoS …, 2021 - journals.plos.org
Acinetobacter baumannii (A. baumannii) represents a global threat owing to its ability to
resist most of the currently available antimicrobial agents. Moreover, emergence of …

Molecular Epidemiology of Extensively-Drug Resistant Acinetobacter baumannii Sequence Type 2 Co-Harboring blaNDM and blaOXA From Clinical Origin

H Ejaz, M Ahmad, S Younas, K Junaid… - Infection and Drug …, 2021 - Taylor & Francis
Background The therapeutic management of carbapenem-resistant Acinetobacter
baumannii (CR-AB) represents a serious challenge to the public health sector because …

Co-Existence of blaNDM-1, blaOXA-23, blaOXA-64, blaPER-7 and blaADC-57 in a Clinical Isolate of Acinetobacter baumannii from Alexandria, Egypt

S Sánchez-Urtaza, A Ocampo-Sosa… - International Journal of …, 2023 - mdpi.com
The increasing rates of antimicrobial resistance among carbapenem-resistant Acinetobacter
baumannii in the Middle East and North Africa are one of the major concerns for healthcare …

Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23

AMS El Bannah, NN Nawar, RMM Hassan… - Microbial Drug …, 2018 - liebertpub.com
Of great concern is the increased frequency of carbapenem-resistant Acinetobacter
baumannii (CRAB) causing healthcare-associated infections. Different classes of β …

[HTML][HTML] Phenotypic and genotypic evaluation of antibiotic resistance of Acinetobacter baumannii bacteria isolated from surgical intensive care unit patients in Pakistan

N Zahra, B Zeshan, MMA Qadri, M Ishaq… - Jundishapur Journal of …, 2021 - brieflands.com
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) is a significant
nosocomial pathogen, causing serious threats concerning community-wide outbreaks …

[HTML][HTML] Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

A Vahhabi, A Hasani, MA Rezaee… - Iranian Journal of …, 2021 - ncbi.nlm.nih.gov
Materials and Methods: A. baumannii (n= 112) isolates were recovered from various clinical
specimens of patients admitted in internal, surgery, burn, infectious diseases and various …

Molecular epidemiology of carbapenem‐resistant Acinetobacter baumannii isolated from three major hospitals in Jordan

Q Ababneh, N Aldaken, Z Jaradat… - … Journal of Clinical …, 2021 - Wiley Online Library
Background In the last decade, incidences of carbapenem‐resistant Acinetobacter
baumannii have been increasingly reported worldwide. Consequently, A. baumannii was …

Prevalence of carbapenem resistant acinetobacter baumannii (CRAB) in some Egyptian hospitals: evaluation of the use of blaOXA-51-like gene as species specific …

S Tolba, EH El Shatoury… - Egyptian Journal of …, 2019 - journals.ekb.eg
CARBAPENEM resistant Acinetobacter baumannii (CRAB) now leads the WHO's critical
priority list of nosocomial pathogens worldwide. Carbapenem Hydrolysing Class D β …